The attitudes of physicians toward guideline recommendations for the management of dyslipidemia in clinical practice-The VIPFARMA ISCP Project

R Lopez-Santi, D Piskorz, S Garcia-Zamora… - Current Problems in …, 2023 - Elsevier
The aim of this study was to explore the different attitudes of physicians regarding
international recommendations for the management of dyslipidemia in routine medical …
被引用次数：2 相关文章
[DOC] sgul.ac.uk

[DOC][DOC] The attitudes of physicians toward guideline recommendations for the management of dyslipidemia in clinical practice-The VIPFARMA ISCP Project.

R Lopez-Santi, D Piskorz, S Garcia-Zamora, D Martinez… - openaccess.sgul.ac.uk
Guideline recommendations for the management of dyslipidemia, based on current trial
evidence and/or expert consensus, aim at improving atherosclerotic cardiovascular disease …

The Attitudes of Physicians Toward Guideline Recommendations for the Management of Dyslipidemia in Clinical Practice-The VIPFARMA ISCP Project

R Lopez-Santi, D Piskorz… - Current problems …, 2023 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to explore the different attitudes of physicians regarding
international recommendations for the management of dyslipidemia in routine medical …

[引用][C] The attitudes of physicians toward guideline recommendations for the management of dyslipidemia in clinical practice-The VIPFARMA ISCP Project.

R Lopez-Santi, D Piskorz, S Garcia-Zamora… - Current Problems in …, 2022 - europepmc.org
The attitudes of physicians toward guideline recommendations for the management of
dyslipidemia in clinical practice - The VIPFARMA ISCP Project. - Abstract - Europe PMC Sign in …

The attitudes of physicians toward guideline recommendations for the management of dyslipidemia in clinical practice-The VIPFARMA ISCP Project

R Lopez-Santi, D Piskorz… - Current Problems in …, 2022 - openaccess.sgul.ac.uk
Guideline recommendations for the management of dyslipidemia, based on current trial
evidence and/or expert consensus, aim at improving atherosclerotic cardiovascular disease …